Lipids, lipid complexes and use thereof
US-2015359906-A1 · Dec 17, 2015 · US
US12071393B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12071393-B2 |
| Application number | US-202117407276-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 20, 2021 |
| Priority date | Aug 21, 2020 |
| Publication date | Aug 27, 2024 |
| Grant date | Aug 27, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention generally relates to a process for selective and direct activation and subsequent amidation of aliphatic and aromatic carboxylic acids to afford an amide R 3 CONR 1 R 2 . That the process is capable of delivering gaseous or low-boiling point amines provides a major advantage over existing methodologies, which involves an intermediate of triacyloxyborane-amine complex [(R 3 CO 2 ) 3 —B—NHR 1 R 2 ]. This procedure readily produces primary, secondary, and tertiary amides, and is compatible with the chirality of the acid and amine involved. The preparation of known pharmaceutical molecules and intermediates has also been demonstrated.
Opening claim text (preview).
The invention claimed is: 1. A triacyloxyborane-amine complex comprising [(R 3 CO 2 ) 3 —B −1 —N +1 H(R 1 )R 2 ], wherein R 3 is an aryl, each of which is optionally substituted; R 1 and R 2 are, independently, hydrogen, an alkyl, or an aryl, wherein said alkyl or aryl are optionally substituted and said R 1 and R 2 are not both an aryl, an alkyl, or a hydrogen at the same time. 2. The triacyloxyborane-amine complex [(R 3 CO 2 ) 3 —B −1 —N +1 H(R 1 )R 2 ], according to claim 1 , wherein said triacyloxyborane-amine complex [(R 3 CO 2 ) 3 —B −1 —N +1 H(R 1 )R 2 ] is manufactured as following: a. preparing an amine-borane (R 1 )R 2 N—BH 3 from an amine R 1 R 2 NH; wherein R 1 and R 2 are, independently, hydrogen, an alkyl, or an aryl, wherein said alkyl or aryl are optionally substituted and said R 1 and R 2 are not both an aryl, and alkyl, or a hydrogen at the same time; b. preparing a carboxylic acid R 3 COOH, wherein R 3 is an aryl, which is optionally substituted; c. dissolving one equivalent of said amine-borane and about three equivalents of said carboxylic acid in xylenes or a compatible solvent to afford a reaction mixture; and d. heating said reaction mixture to about 90-100° C. for about 1 hour to afford said said triacyloxyborane-amine complex [(R 3 CO 2 ) 3 —B −1 —N +1 H(R 1 )R 2 ]. 3. A product manufactured using the triacyloxyborane-amine complex according to claim 1 . 4. An active pharmaceutical ingredient manufactured using the triacyloxyborane-amine complex according to claim 1 .
having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title
in position 3 · CPC title
from aromatic carboxylic acids · CPC title
with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings · CPC title
Y being a hydrogen or an acyclic carbon atom · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.